Zomedica (NYSEAMERICAN:ZOM – Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Thursday, March 13th. Analysts expect Zomedica to post earnings of ($0.01) per share and revenue of $8.10 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Zomedica Trading Down 0.2 %
Shares of NYSEAMERICAN ZOM opened at $0.10 on Thursday. The company has a market cap of $95.35 million, a price-to-earnings ratio of -1.62 and a beta of 1.03. Zomedica has a twelve month low of $0.09 and a twelve month high of $0.20. The firm’s fifty day moving average price is $0.12.
Analysts Set New Price Targets
Separately, Noble Financial upgraded Zomedica to a “strong-buy” rating in a research note on Monday, November 11th.
Zomedica Company Profile
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
Recommended Stories
- Five stocks we like better than Zomedica
- How to Read Stock Charts for Beginners
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- 3 Fintech Stocks With Good 2021 Prospects
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What is an Earnings Surprise?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Zomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica and related companies with MarketBeat.com's FREE daily email newsletter.
